NLG802 |
| Katalog-Nr.GC64955 |
NLG802 ist ein Prodrug von Indoximod, einem oral wirksamen Inhibitor der Indolamin-2,3-Dioxygenase (IDO).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2071683-99-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
NLG802 is a prodrug of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.
[1]. Kumar S, et al. Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur J Med Chem. 2020 Jul 15;198:112373.
Review for NLG802
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for NLG802
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *